The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 3,003,725 | 36,851 | SH | SOLE | 36,851 | 0 | 0 | ||
| CURIS INC | COM | 231269309 | 148,741 | 284,889 | SH | SOLE | 284,889 | 0 | 0 | ||
| FRACTYL HEALTH INC | COM | 35168W103 | 1,474,499 | 1,856,117 | SH | SOLE | 1,856,117 | 0 | 0 | ||
| INVIVYD INC | COM | 00534A102 | 8,068,173 | 9,248,250 | SH | SOLE | 9,248,250 | 0 | 0 | ||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 1,115,615 | 599,793 | SH | SOLE | 599,793 | 0 | 0 | ||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 721,179 | 210,871 | SH | SOLE | 210,871 | 0 | 0 | ||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 1,111,209 | 101,203 | SH | SOLE | 101,203 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 4,854,169 | 88,354 | SH | SOLE | 88,354 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 26,657,930 | 4,588,284 | SH | SOLE | 4,588,284 | 0 | 0 | ||